This enzyme fixes the ends of our DNA
No instructions or measurements
It depends on your specific situation, your risk tolerance, your timeline, and what you are optimizing for
The most common adverse effect involves scalp irritation, occurring in 5-10% of users and typically presenting as itching, dryness, flaking, or dermatitis
Epidemiological Evidence of Post-COVID IBS At 12-month follow-up, patients with COVID-19 had significantly higher IBS rates compared with controls (3.2% vs 0.5%, p=0.045). Post-COVID-19 IBS Integrative Review Authors , Authors of a peer-reviewed integrative review on post-COVID-19 IBS Mounting evidence points to a significant relationship between SARS-CoV-2 infection and subsequent development of irritable bowel syndrome, with expanding research now quantifying this association across diverse patient populations